Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Seidman

Showing results (41-50 of 386) with videos related to

Pageof 39
Sort By:
The Laryngoscope|July 5, 2005
Is oxymetazoline really safe for middle ear useMichael D Seidman
Seminars in Oncology|July 14, 1999
Single-agent paclitaxel in the treatment of breast cancer: phase I and II developmentA D Seidman
Archives of Otolaryngology--Head & Neck Surgery|November 11, 1999
Hot-water irrigation in the treatment of posterior epistaxisM D Seidman
The New England Journal of Medicine|May 9, 1991
Case 2-1990J D Seidman
Nature Clinical Practice. Oncology|April 6, 2006
Is trastuzumab active following conventional adjuvant chemotherapy in HER2-positive early breast cancer?Andrew D Seidman
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2013
New advances in taxane therapy: the next generationAndrew D Seidman
Human Pathology|February 1, 1997
Interlaboratory reproducibility of the interpretation of flow cytometric DNA histogramsJ D Seidman
Histopathology|April 17, 1998
Ovarian atypical endometriosisJ D Seidman
JAMA|April 9, 1998
Risks and benefits of varicella vaccineD Seidman, E Pont
Hearing Research|June 26, 2001
A specific mitochondrial DNA deletion (mtDNA4977) is identified in a pedigree of a family with hearing lossU Bai, M D Seidman
Pageof 39

Showing results (41-50 of 386) with videos related to

Sort By:
Pageof 39
The Laryngoscope|July 5, 2005
Is oxymetazoline really safe for middle ear useMichael D Seidman
Seminars in Oncology|July 14, 1999
Single-agent paclitaxel in the treatment of breast cancer: phase I and II developmentA D Seidman
Archives of Otolaryngology--Head & Neck Surgery|November 11, 1999
Hot-water irrigation in the treatment of posterior epistaxisM D Seidman
The New England Journal of Medicine|May 9, 1991
Case 2-1990J D Seidman
Nature Clinical Practice. Oncology|April 6, 2006
Is trastuzumab active following conventional adjuvant chemotherapy in HER2-positive early breast cancer?Andrew D Seidman
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2013
New advances in taxane therapy: the next generationAndrew D Seidman
Human Pathology|February 1, 1997
Interlaboratory reproducibility of the interpretation of flow cytometric DNA histogramsJ D Seidman
Histopathology|April 17, 1998
Ovarian atypical endometriosisJ D Seidman
JAMA|April 9, 1998
Risks and benefits of varicella vaccineD Seidman, E Pont
Hearing Research|June 26, 2001
A specific mitochondrial DNA deletion (mtDNA4977) is identified in a pedigree of a family with hearing lossU Bai, M D Seidman
Pageof 39